Anti-inflammatory therapies are associated with delayed onset of anemia and reduction in transfusion requirements in critically ill patients: results from two studies.
Madelief BolscherStephanie C E KosterMatty KoopmansJelle L G Haitsma MulierLennie P G DerdeNicole P JuffermansPublished in: Critical care (London, England) (2024)
Immunomodulatory treatment was associated with a slower decline in Hb level in critically ill patients with COVID-19 and with less transfusion. Findings point toward inflammation as an important cause for the occurrence of anemia in the critically ill.